The low number and density of pericytes in the cortex and hippocampus of AD patients lead to the upregulation of Aβ and p-tau proteins, causing microglial activation, neuroinflammation, neuronal degeneration, and cognitive impairment [140,141]. Here, MAPT is linked to Alzheimer disease.